📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: OraPharma

1.1 - Company Overview

OraPharma Logo

OraPharma

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of specialty pharmaceutical and oral health solutions for dental professionals, developing and commercializing advanced products. Offerings include Arestin (minocycline HCl) Microspheres, 1 mg, an antibiotic used with scaling and root planing to treat periodontal disease; the OSSIX portfolio of dental regenerative products; a Student Access program for dental hygiene students; and partnerships with over 35 dental service organizations nationwide.

Products and services

  • Dental Service Organizations: Nationwide-scale partnerships with over 35 dental service organizations ensure dental practices have access to OraPharma oral health products and services across the country
  • Arestin®: Pharmaceutical-grade, locally administered minocycline HCl microspheres (1 mg) antibiotic used in conjunction with scaling and root planing procedures to treat periodontal disease
  • OSSIX® Portfolio: Partnership-developed range of dental regenerative products, created with Datum Dental Ltd., supporting dental procedures and improving oral health

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to OraPharma

Kohler Medizintechnik Logo

Kohler Medizintechnik

HQ: Germany Website
  • Description: Provider of dental instruments for dentistry, oral implantology, and jaw surgery, offering needle holders, pliers, scalpel blades and holders, dental forceps, gouge tongs, root elevators, clamps, and bone files.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Kohler Medizintechnik company profile →
DryShield Logo

DryShield

HQ: United States Website
  • Description: Provider of an all-in-one isolation system that performs the tasks of a high-suction evacuator, saliva ejector, and bite block.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full DryShield company profile →
Specialty Appliances Logo

Specialty Appliances

HQ: United States Website
  • Description: Provider of orthodontic appliances, including Clear Image Aligners for teeth alignment with practitioner-controlled treatment adjustments; 3D Indirect Bonding with digitally placed brackets and custom trays for accurate placement; Specialty M4 Herbst for Class II correction allowing lateral movement and incisal opening; Guardian Invisible Retention System with multiple clear retainers and a printed model; and Hybrid Complete combining braces and aligners.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Specialty Appliances company profile →
Elexxion Logo

Elexxion

HQ: Germany Website
  • Description: Provider of dental laser medical devices for soft and hard tissue applications, developing, manufacturing, and marketing diode lasers for dentistry, oral and dental surgery, orthodontics, and periodontology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Elexxion company profile →
Phibo Logo

Phibo

HQ: Spain Website
  • Description: Provider of technological innovation and digital transformation in dental implantology, offering Sinergia—an integrated digital workflow connecting clinics, laboratories, Phibo, and patients; Aurea Evo—a dental implant system simplifying daily practice and maintaining natural aesthetics; and Adhoc—customizable screwed structures with required connections in various materials.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Phibo company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for OraPharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to OraPharma

2.2 - Growth funds investing in similar companies to OraPharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for OraPharma

4.2 - Public trading comparable groups for OraPharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to OraPharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About OraPharma

What does OraPharma do?

OraPharma is a provider of specialty pharmaceutical and oral health solutions for dental professionals, developing and commercializing advanced products. Offerings include Arestin (minocycline HCl) Microspheres, 1 mg, an antibiotic used with scaling and root planing to treat periodontal disease; the OSSIX portfolio of dental regenerative products; a Student Access program for dental hygiene students; and partnerships with over 35 dental service organizations nationwide.

Who are OraPharma's competitors?

OraPharma's competitors and similar companies include Kohler Medizintechnik, DryShield, Specialty Appliances, Elexxion, and Phibo.

Where is OraPharma headquartered?

OraPharma is headquartered in United States.

How many employees does OraPharma have?

OraPharma has 1,000 employees 🔒.

When was OraPharma founded?

OraPharma was founded in 2010 🔒.

What sector and industry vertical is OraPharma in?

OraPharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for OraPharma

Who are the top strategic acquirers in OraPharma's sector and industry

Top strategic M&A buyers and acquirers in OraPharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for OraPharma?

Top strategic M&A buyers groups and sectors for OraPharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in OraPharma's sector and industry vertical

Which are the top PE firms investing in OraPharma's sector and industry vertical?

Top PE firms investing in OraPharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in OraPharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in OraPharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in OraPharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to OraPharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in OraPharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for OraPharma?

The key public trading comparables and valuation benchmarks for OraPharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for OraPharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for OraPharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in OraPharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for OraPharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in OraPharma's' sector and industry vertical?

Access recent funding rounds and capital raises in OraPharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for OraPharma

Launch login modal Launch register modal